Powered by: Motilal Oswal
2025-11-14 12:10:30 pm | Source: Accord Fintech
Excel Industries moves up on signing binding term sheet to supply specialty chemical
Excel Industries moves up on signing binding term sheet to supply specialty chemical

Excel Industries is currently trading at Rs. 998.00, up by 3.50 points or 0.35% from its previous closing of Rs. 994.50 on the BSE.

The scrip opened at Rs. 989.10 and has touched a high and low of Rs. 998.00 and Rs. 989.10 respectively. So far 98 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 5 has touched a 52 week high of Rs. 1745.00 on 14-Nov-2024 and a 52 week low of Rs. 798.50 on 03-Mar-2025.

Last one week high and low of the scrip stood at Rs. 1245.00 and Rs. 989.10 respectively. The current market cap of the company is Rs. 1254.56 crore.

The promoters holding in the company stood at 52.68%, while Institutions and Non-Institutions held 8.80% and 38.52% respectively.

Excel Industries has signed a binding term sheet with a leading Indian specialty chemicals company for the supply of a Specialty Chemical. The supply period as per the term sheet is 5 years. The projected revenue generation (from Jobwork Charges) for the company is Rs 35 - 40 crore per annum.

The company will be commissioning a dedicated line for effecting the above supplies. The plant is expected to be commissioned in June 2026. The estimated CAPEX for the project is around Rs 40 crore. The company will receive Rs 25 crore as trade advance from the customer.

Excel Industries is engaged in manufacturing of Agrochemical intermediates, phosphates, speciality chemicals, biocides and pharma products.

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here